Cargando…

Differential immunomodulation of porcine bone marrow derived dendritic cells by E. coli Nissle 1917 and β-glucans

In early life and around weaning, pigs are at risk of developing infectious diseases which compromise animal welfare and have major economic consequences for the pig industry. A promising strategy to enhance resistance against infectious diseases is immunomodulation by feed additives. To assess the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geervliet, Mirelle, Lute, Laura C. P., Jansen, Christine A., Rutten, Victor P. M. G., Savelkoul, Huub F. J., Tijhaar, Edwin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304589/ https://www.ncbi.nlm.nih.gov/pubmed/32559198 http://dx.doi.org/10.1371/journal.pone.0233773

Ejemplares similares

Effects of Escherichia coli Nissle 1917 on the Porcine Gut Microbiota, Intestinal Epithelium and Immune System in Early Life
por: Geervliet, Mirelle, et al.
Publicado: (2022)

Impact of Yeast-Derived β-Glucans on the Porcine Gut Microbiota and Immune System in Early Life
por: de Vries, Hugo, et al.
Publicado: (2020)

E. coli Nissle 1917 Affects Salmonella Adhesion to Porcine Intestinal Epithelial Cells
por: Schierack, Peter, et al.
Publicado: (2011)

Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
por: Yu, Xiaoli, et al.
Publicado: (2019)

Gradient Magnetic Field Accelerates Division of E. coli Nissle 1917
por: Gorobets, Svitlana, et al.
Publicado: (2023)

Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages
por: Hu, Rujiu, et al.
Publicado: (2020)

Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
por: Pérez-Berezo, Teresa, et al.
Publicado: (2017)

Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917
por: Massip, Clémence, et al.
Publicado: (2019)

The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice
por: Rodríguez-Nogales, Alba, et al.
Publicado: (2018)

Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
por: Ukena, Sya N., et al.
Publicado: (2007)

The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
por: Bury, Susanne, et al.
Publicado: (2018)

Engineered E. coli Nissle 1917 for the reduction of vancomycin‐resistant Enterococcus in the intestinal tract
por: Geldart, Kathryn G., et al.
Publicado: (2018)

Effects of Escherichia coli strain Nissle 1917 on exercise-induced disruption of gastrointestinal integrity
por: Mooren, F. C., et al.
Publicado: (2020)

Transcriptional Profiling of the Probiotic Escherichia coli Nissle 1917 Strain under Simulated Microgravity
por: Yim, Jaewoo, et al.
Publicado: (2020)

Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
por: Praveschotinunt, Pichet, et al.
Publicado: (2019)

No Genotoxicity Is Detectable for Escherichia coli Strain Nissle 1917 by Standard In Vitro and In Vivo Tests
por: Dubbert, Silke, et al.
Publicado: (2020)

Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model
por: Park, Jihye, et al.
Publicado: (2021)

Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917
por: Kan, Anton, et al.
Publicado: (2020)

Escherichia coli Nissle 1917 inhibits biofilm formation and mitigates virulence in Pseudomonas aeruginosa
por: Aljohani, Ahmad M., et al.
Publicado: (2023)

Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy
por: Tumas, Sarunas, et al.
Publicado: (2023)

Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity
por: Olier, Maïwenn, et al.
Publicado: (2012)

Functional investigation of the chromosomal ccdAB and hipAB operon in Escherichia coli Nissle 1917
por: Xu, Jun, et al.
Publicado: (2020)

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917
por: Dusek, Otakar, et al.
Publicado: (2020)

A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917
por: Nougayrède, Jean-Philippe, et al.
Publicado: (2021)

E. coli Nissle 1917 modulates host glucose metabolism without directly acting on glucose
por: Chavkin, Theodore A., et al.
Publicado: (2021)

Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment
por: Zhao, Rui, et al.
Publicado: (2022)

Efficient markerless integration of genes in the chromosome of probiotic E. coli Nissle 1917 by bacterial conjugation
por: Seco, Elena M., et al.
Publicado: (2021)

Antibacterial MccM as the Major Microcin in Escherichia coli Nissle 1917 against Pathogenic Enterobacteria
por: Ma, Yi, et al.
Publicado: (2023)

Agaricus subrufescens fermented rye affects the development of intestinal microbiota, local intestinal and innate immunity in suckling-to-nursery pigs
por: Wen, Caifang, et al.
Publicado: (2023)

Escherichiacoli Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy
por: Liu, Qingyao, et al.
Publicado: (2021)

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers
por: Henker, Jobst, et al.
Publicado: (2007)

Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance
por: Nzakizwanayo, Jonathan, et al.
Publicado: (2015)

Insights from the molecular characterization of mercury stress proteins identified by proteomics in E.coli nissle 1917
por: Seshapani, Panthangi, et al.
Publicado: (2013)

Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth
por: He, Lian, et al.
Publicado: (2017)

Serial passage in an insect host indicates genetic stability of the human probiotic Escherichia coli Nissle 1917
por: Schröder, Nicolas C H, et al.
Publicado: (2022)

Structural characterization of phosphoethanolamine-modified lipid A from probiotic Escherichia coli strain Nissle 1917
por: Jo, Sung-Hyun, et al.
Publicado: (2019)

Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment
por: Manzhalii, Elina, et al.
Publicado: (2022)

Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota
por: Teng, Guigen, et al.
Publicado: (2022)

High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917
por: van ‘t Hof, Max, et al.
Publicado: (2022)

Bioengineering of Escherichia coli Nissle 1917 for Production and Excretion of Spermidine, a Key Metabolite in Human Health
por: Caffaratti, Clément, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0mfkuhbumcbfpa2b817hje8esb